Mobia Medical Inc 2026年季度报告

FORM 10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2026 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission File Number: 001-43275 MOBIA MEDICAL, INC.(Exact name of registrant as specified in its charter) Delaware(State or other jurisdiction ofincorporation or organization) 20-8573833(I.R.S. EmployerIdentification No.) 2802 Flintrock Trace, Suite 226Austin, TX(Address of principal executive offices) 78738(Zip Code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registeredThe Nasdaq Stock Market LLC MOBI Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes☐No☒Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Non-accelerated filer☒ Smaller reporting company☒ Emerging growth company☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ As of June 1, 2026, there were 33,249,006 shares of the registrant’s common stock, par value $0.01 per share, outstanding. Mobia Medical, Inc. TABLE OF CONTENTS PART I—FINANCIAL INFORMATION Item 1. Condensed Financial Statements6Condensed Balance Sheets (unaudited) as of March 31, 2026 and December 31, 20256Condensed Statements of Operations (unaudited) for the three months ended March 31, 2026 and 20257Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit (unaudited) for thethree months ended March 31, 2026 and 20258Condensed Statements of Cash Flows (unaudited) for the three months ended March 31, 2026 and 20259Notes to Condensed Financial Statements10Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations27Item 3. Quantitative and Qualitative Disclosures About Market Risk37Item 4. Controls and Procedures37PART II—OTHER INFORMATION39Item 1. Legal Proceedings39Item 1A. Risk Factors39Item 2. Unregistered Sales of Equity Securities and Use of Proceeds89Item 3. Defaults Upon Senior Securities90Item 4. Mine Safety Disclosures90Item 5. Other Information90Item 6. Exhibits90SIGNATURES93 Special Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federalsecurities laws. All statements other than statements of historical facts contained in this Quarterly Report, including statementsregarding our expectations of future results of operations and financial condition, business strategy, solutions, technology, R&Dcosts, regulatory approvals, potential market opportunity, anticipated trends in our business, timing and likelihood of success, as wellas plans and objectives of management for future operations, are forward-looking statements. These statements involve known andunknown risks, uncertainties, and other important factors that are in some cases beyond our control and may cause our actual results,performance, or achievements to be materially different from any future results, performance, or achievements expressed or impliedby the forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,”“potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these terms or other similar expressions,are intended to identify forward-looking statements. Forward-looking statements contained in this Quarterly Report include, but arenot limited to, statements about: •the expected growth of our business and our organization;•our ability to continue as a going concern;•our ability to retain and recruit key personnel, including the continued development of a sales and mar